A pair of Bay­er ex­ecs land pro­mo­tions in the US; En­er­gized by lenzilum­ab da­ta, Hu­mani­gen taps As­traZeneca alum as CMO

→ Bay­er has hand­ed out two pro­mo­tions in its US op­er­a­tions, with Nel­son Am­bro­gio and John Berrios both get­ting the bump. Am­bro­gio be­comes SVP, gen­er­al man­ag­er of on­col­o­gy, while Berrios take Am­bro­gio’s place as SVP, gen­er­al man­ag­er of women’s health­care. Am­bro­gio is a long­time Bay­er vet who’s held such ti­tles in­ter­na­tion­al­ly as gen­er­al man­ag­er in Aus­tralia and New Zealand and man­ag­ing di­rec­tor in Por­tu­gal. Berrios, who joined Bay­er in 2016 af­ter 15 years at As­traZeneca, takes on his new re­spon­si­bil­i­ties af­ter a year as VP, com­mer­cial op­er­a­tions.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER